Syros Pharmaceuticals, Inc. SYRS
SYRS
Syros Pharmaceuticals, Inc. VINC
Vincerx Pharma, Inc. KTTA
Pasithea Therapeutics Corp. COEP
Coeptis Therapeutics, Inc. REVB
Revelation Biosciences, Inc. VRPX
Virpax Pharmaceuticals, Inc. NKGN
NKGen Biotech, Inc. Common Stock DRMA
Dermata Therapeutics, Inc. SLXNW
Silexion Therapeutics Ltd. NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares
Syros Pharmaceuticals, Inc. VINC
Vincerx Pharma, Inc. KTTA
Pasithea Therapeutics Corp. COEP
Coeptis Therapeutics, Inc. REVB
Revelation Biosciences, Inc. VRPX
Virpax Pharmaceuticals, Inc. NKGN
NKGen Biotech, Inc. Common Stock DRMA
Dermata Therapeutics, Inc. SLXNW
Silexion Therapeutics Ltd. NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares
Performance
| Periode | SYRS | VINC | KTTA | COEP | REVB | VRPX | NKGN | DRMA | SLXNW | NUVO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -99.26 % | -75.47 % | 64.05 % | 117.30 % | -63.02 % | -92.47 % | -77.58 % | 249.68 % | -32.65 % | 21 150.00 % |
| YTD | -99.91 % | -99.72 % | -59.73 % | 159.22 % | -97.28 % | -99.78 % | -92.76 % | 58.99 % | 31.47 % | 8 400.00 % |
| 1Y | -99.90 % | -99.67 % | -55.64 % | 449.10 % | -94.09 % | -99.76 % | -92.22 % | 79.67 % | 32.20 % | 8 400.00 % |
| 3Y | -99.99 % | -99.93 % | -89.79 % | -44.89 % | -99.99 % | -99.99 % | -99.12 % | -94.94 % | -80.59 % | -97.54 % |
| 5Y | -100.00 % | -100.00 % | -98.34 % | -92.28 % | -100.00 % | -100.00 % | -99.12 % | -99.82 % | -80.59 % | -97.54 % |
| 10Y | -100.00 % | -99.99 % | -98.34 % | -92.26 % | -100.00 % | -100.00 % | -99.12 % | -99.82 % | -80.59 % | -97.54 % |
| From the beginning | -100.00 % | -99.99 % | -98.34 % | -92.26 % | -100.00 % | -100.00 % | -99.12 % | -99.82 % | -80.59 % | -97.54 % |